Potential roles for tumor necrosis factor and nuclear factor-kappaB in seizure activity.
Albensi
B C
BC
Department of Neurological Surgery, Cerebrovascular Research Center, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA. albens@ccf.org
D000818:Animals; D001253:Astrocytes / Q000187:drug effects / Q000378:metabolism; D002545:Brain Ischemia / Q000150:complications / Q000503:physiopathology; D002460:Cell Line; D016207:Cytokines / Q000502:physiology; D004827:Epilepsy / Q000378:metabolism / Q000503:physiopathology*; D005544:Forecasting; D005786:Gene Expression Regulation; D005911:Gliosis / Q000209:etiology / Q000473:pathology; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D008959:Models, Neurological; D016328:NF-kappa B / Q000502:physiology*; D009410:Nerve Degeneration / Q000139:chemically induced / Q000503:physiopathology; D009414:Nerve Growth Factors / Q000502:physiology; D009473:Neuronal Plasticity; D018124:Receptors, Tumor Necrosis Factor / Q000187:drug effects / Q000235:genetics / Q000502:physiology; D011994:Recombinant Proteins / Q000494:pharmacology; D012640:Seizures / Q000378:metabolism / Q000503:physiopathology*; D015398:Signal Transduction; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology / Q000502:physiology*
D016207:Cytokines; D016328:NF-kappa B; D009414:Nerve Growth Factors; D018124:Receptors, Tumor Necrosis Factor; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha